At today's Annual General Meeting of Swiss Life Holding Ltd, shareholders approved all resolutions proposed by the Board of Directors, including the total gross dividend distribution of CHF 20.00 per registered share.
The Annual General Meeting of Swiss Life Holding Ltd was held without any shareholders present at Swiss Life head office in Zurich, following the instructions in Ordinance 2 issued by the Federal Council on 16 March 2020 on measures to combat the coronavirus. In the run-up to the General Meeting, Swiss Life had asked its shareholders to have their voting right exercised by the independent voting representative in view of the special situation. The independent voting representative represented 15,408 million of the voting rights (45,87% of the share capital).
Shareholders voted with 99,76% in favour of the proposed ordinary dividend of CHF 15.00 gross per registered share for the 2019 financial year. The total distribution of CHF 20.00 is made up of this ordinary dividend from profit of CHF 15.00 and a repayment of par value in the amount of CHF 5.00, which was approved with 92,64%. The distribution of the ordinary dividend of CHF 9.75 net per share will be paid with value date of 5 May 2020. The repayment of par value to shareholders of CHF 5.00 per share will take place on 24 July 2020. The General Meeting confirmed Rolf Dörig as Chairman of the Board of Directors and also confirmed the other members of the Board of Directors for an extra term of office of one year each.
Publication of the financial condition report
Swiss Life also published its financial condition report today. This reporting with additional information regarding the already published 2019 annual report contains details of the solvency of Swiss Life in addition to information concerning operating activity, governance and risk management. It is available at www.swisslife.com/results.
Phone +41 43 284 77 77
Phone +41 43 284 52 76
Follow us on Twitter
All our media releases can be found at swisslife.com/mediareleases
The Swiss Life Group is one of Europe's leading comprehensive life and pensions and financial solutions providers. In its core markets of Switzerland, France and Germany, Swiss Life offers individuals and corporations comprehensive and individual advice plus a broad range of own and partner products through its sales force and distribution partners such as brokers and banks.
Swiss Life Select, Tecis, Horbach, Proventus, Fincentrum and Chase de Vere advisors choose suitable products for customers from the market according to the Best Select approach. Swiss Life Asset Managers offers institutional and private investors access to investment and asset management solutions. Swiss Life provides multinational corporations with employee benefits solutions and high net worth individuals with structured life and pensions products.
Swiss Life Holding Ltd, registered in Zurich, was founded in 1857 as Schweizerische Rentenanstalt. The shares of Swiss Life Holding Ltd are listed on the SIX Swiss Exchange (SLHN). The subsidiaries Livit, Corpus Sireo, Beos, Mayfair Capital and Fontavis are also part of the Swiss Life Group. The Group employs a workforce of around 9300 and has at its disposal a distribution network of some 14 000 advisors.
Cautionary statement regarding forward-looking information
This publication contains specific forward-looking statements, e.g. statements including terms like “believe”, “assume”, “expect” or similar expressions. Such forward-looking statements, by their nature, are subject to known and unknown risks, uncertainties and other important factors. These may result in a substantial divergence between the actual results, developments and expectations of Swiss Life and those explicitly or implicitly described in these forward-looking statements. Given these uncertainties, the reader is reminded that these statements are merely projections and should not be overvalued. Neither SwissLife nor its Members of the Board of Directors, executive managers, managers, employees or external advisors nor any other person associated with Swiss Life or with any other relationship to the company makes any express or implied representation or warranty as to the correctness or completeness of the information contained in this publication. SwissLife and the abovementioned persons shall not be liable under any circumstances for any direct or indirect loss resulting from the use of this information. Furthermore, Swiss Life undertakes no obligation to publicly update or change any of these forward-looking statements, or to adjust them to reflect new information, future events, developments or similar.